taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.
scott cadger, head of underwriting and claims strategy at scottish widows, said the industry needed to do more to educate the public on the merits of protection insurance.
.
.
why novartis� landmark cancer drug approval is great news for bluebird
.
.
.
andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment.
.
. northern ireland health trust keeps dr watt patient recall report secret
. german chancellor angela merkel (bottom left) was straightforward when she said enlargment was not on the table at the sofia summit .
.
.